PhenoImager Assays and Reagents
Shifting the paradigm from visual IHC to quantitative IF with Opal
Image Multiple Tissue Biomarkers in Context
Akoya’s Opal™ Multiplex IHC kits make multiplex results accessible to anyone who works with standard immunohistochemistry. With Opal technology, you can select antibodies for simultaneous IHC detection based on performance rather than species. Opal kits are optimized for reliable Multispectral Imaging (MSI) for simultaneous measurement of three to eight IHC targets, plus a nuclear stain.
Opal enables you to:
- Accomplish better phenotypic scoring and quantification by using signal amplification
- Reduce overall sample and reagent consumption with increased plexing
- Achieve excellent resolution with low background
- Reach up to 4 logs dynamic range compared to 1 log using chromogenic assay detection techniques
Opal Kits & Reagents
Opal Predesigned Panels for Automated PhenoImager Workflows
Opal Antibody Panel Kits provide pre-optimized, ready-to-use primary antibodies and detection reagents designed for use with automated staining and PhenoImager™ Fusion and PhenoImager™ HT (formerly Vectra Polaris) instruments and offer a validated end-to-end solution for unparalleled quantitative data in translational immuno-oncology research.
Innovative Rapid Whole Slide Panel Kits (patent pending)
- Easy-to-Use – Fully validated plug-and-play multiplex immunofluorescence staining protocol.
- Flexible – Adjustable signal intensity for your sample’s unique biomarker expression levels.
- Powerful – Unlock the full impact of whole slide multispectral workflows with Akoya’s kits when used with the PhenoImager Fusion and PhenoImager HT (formerly Vectra Polaris) and inForm analysis software.
Opal Multiplex IHC Detection Kits
Opal for multiplex immunofluorescence in formalin-fixed, paraffin-embedded (FFPE) tissue can be performed manually or via automation. Opal enable the development of multiplexed assays with balanced, quantitative signal for rare and abundant targets, imaged in a single, final scan with the Akoya portfolio of multispectral imagers, including the PhenoImager Fusion and PhenoImager HT.
Automated Opal Multiplex IHC Detection Kits
These Opal detection kits allow user to perform multiplex staining using an automated staining platform. Automation provides the flexibility to support the dynamic demands of translational research
Manual Opal Multiplex Predesigned Panels and IHC Detection Kits
These Opal kits offer users a manual method that is similar to standard immunohistochemistry (IHC) making them accessible to many laboratories where standard IHC method development is performed.
Opal Fluorophore Reagent Packs
Standalone Opal Fluorophore reagent packs allow you to pick and choose your panel’s biomarker quantity and design.
Opal Ancillary Reagents
These ready-to-use ancillary reagents, from diluents to secondary antibodies and blocking buffers, have been optimized specifically for Opal™ multiplex fluorescent immunohistochemistry protocols
Tyramide signal amplification (TSA® staining) typically provides 2-3 logs of sensitivity enhancement over standard fluorescent and hapten based detection methods. TSA staining increases sensitivity while maintaining resolution and dynamic range while allowing reduced consumption of primary antibodies.
Protocol optimization for TSA detection is critical for success with the technique, whether used as part of the PhenoImager multiplex imaging instruments or other detection system.
TSA Reagents for IHC, IF, or ISH
Clinical workflow for quantifying PD-L1 in non-small cell lung cancer (NSCLC)
Chair of Molecular Pathology, Queen’s University Belfast
Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study
The Johns Hopkins Hospital, Akoya Biosciences, Providence Cancer Institute, MD Anderson Cancer Center, Bristol Myers Squibb, Yale University School of Medicine
Characterizing the TIME with TSA-Based Multiplex Immunofluorescence
MDUniversity of California Davis